.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Concordia Pharms Inc Company Profile

« Back to Dashboard

Summary for Applicant: Concordia Pharms Inc

Patents:2
Tradenames:13
Ingredients:11
NDAs:12
Drug Master File Entries: 0
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
DIBENZYLINE
phenoxybenzamine hydrochloride
CAPSULE;ORAL008708-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Concordia Pharms Inc
KAPVAY
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-004Sep 28, 2010DISCNNo<disabled><disabled>
Concordia Pharms Inc
NILANDRON
nilutamide
TABLET;ORAL020169-001Sep 19, 1996DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc